FCM
CVS icon

Fairholme Capital Management’s CVS Health CVS Stock Holding History

Fairholme Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-147,000
Closed -$11.1M – 16
2021
Q1 		$11.1M Buy
147,000
+35,900
+32% +$2.61M 0.91% 6
2020
Q4 		$7.59M Buy
+111,100
New +$7.23M 0.61% 10

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fairholme Capital Management's CVS Position: Q2 2021 in Review

Fairholme Capital Management sold out of CVS Health (CVS) in Q2 2021, closing a stake of 147,000 shares — an estimated $11.1M sold.

Fairholme Capital Management first reported a position in CVS in Q4 2020 and held it in 2 quarters. The position peaked at $11.1M in Q1 2021. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • Fairholme Capital Management reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
  • Fairholme Capital Management sold 147,000 CVS Health shares in Q2 2021, an estimated $11.1M.
  • Fairholme Capital Management first reported a position in CVS Health in Q4 2020 and held it in 2 quarters.
  • Fairholme Capital Management's CVS Health position peaked at $11.1M in Q1 2021.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Fairholme Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.